renewing health
TRANSCRIPT
RENEWING HEALTH aims at implementing large-scale real-life test beds for the validation and subsequent evaluation of innovative telemedicine services using a patient-centred approach and a common rigorous assement methodology
Involving 7800 patients Start 2010-02-01-2012-08-31
Clinical objectives
• The project improves the quality of life of patients suffering from diabetes, chronic obstructive pulmonary or cardiovascular diseases.
Patient/user perspective objectives
• The project will provide coherent clinical services through ICT that take into consideration patients’ and professional users’ needs, capabilities, risks and benefits.
Economic objectives
• The project implements a new healthcare model that is expected to reduce the cost of chronic patients care to the society
Organisational objectives -
• The project intends to create an organisational model for telemedicine services that ensures a safe, clear and efficient pathway for patients
9 regions in Europe
• Norrbotten (Sweden) • Northern Norway (Norway)• South Karelia (Finland) • Carinthia (Austria) • Berlin (Germany) • Thessaly (Greece)• Region of Southern Denmark • Veneto (Italy)• Catalonia (Spain)
Clusters
• Regions are divided in 7 clusters based on similarities in interventions and chronic conditions.
• The project in Norrbotten is in two cluster; diabetes and cardivascular diseases
The project in NorrbottenThe Diabetes Epidemic and tele-
enabled integrated care
• The prevalence of diabetes type II is rising. In Norrbotten the prevalence is 7% of the population.
• Diabetes II is treated mainly by life-style interventions in diet, smoking and physical activity, supported by medical treatment.
• The aim of the treatment is to lower blood glucose, lipids, blood pressure and weight.
The project in Norrbotten The Diabetes Epidemic and tele-
enabled integrated care
• Self-management support is established as an evidence-based intervention for diabetes and it has been concluded that self-management support is effective
11
• To improve patients HbA1c and their health-related quality of life by providing them with technology
• Trial start and end: 01.02.2011 – 31.07.2012
Objective
The intervention
• Participants use their own PC or receive an Android-based tablet PCs (ViewSonic ViewPad 7) with a dedicated software that manages the collection and transmission of their diagnostic measurements.
• An integrated local health application to The National Patient Portal “My health Care Contacts”
Study type
• Randomised parallel group non-blinded trial with an intervention group and a control group (routine care only).
• Four primary healthcare centres• Sample size: 200 / 200
Inclusioncritera
• T2DM diagnosed > 3 months prior to the enrolment • HbA1c > 53mmol/mol• Age > 18 years• Capability of filling questionnaires by their own
language • Being able to use the devices provided • Being cognitively able to participate• Absence of severe comorbidity • Not pregnant
Evaluation
• The evaluation using as a basis the MAST (Model for Assessment of Telemedicine) assessment model.
• Primary outcome: Health-related quality of life (measured with SF-36) (beginning and trial end HbA1c (beginning and trial end)
Evaluation
• Secondary outcome:• Socio-demographic and clinical baseline
characteristics• Economical: All costs of the organisation
calculated for both intervention and control groups.
• Patient perception: the WSD questionnaire
Thank you for listening
Inger Lindberg, assistant professor, RNM, PhD
www.renewinghealth.eu/